Stay updated with breaking news from Solid Tumours. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Sutro Biopharma, Inc. ("Sutro" or the "Company") (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused...
For EU Trade and Medical Media Only. Not to Be Distributed to UK and Benelux Based Media Conditional Marketing Authorisation is based on results from the Phase 1 CHRYSALIS study evaluating amivantamab
If approved by the European Commission, amivantamab will be the first treatment in the European Union specifically targeting EGFR exon 20 insertion mutations for advanced non-small cell lung cancer
Pembrolizumab and olaparib demonstrated antitumor activity and acceptable safety for men with prostate cancer.
Global Roundup: Singapore's AUM Biosciences Raises $27 Million in Series A Financing Round - read this article along with other careers information, tips and advice on BioSpace